EcoDrugPlus

Histone Deacetylase 3

Ensembl ID : ENSSLDG00000024495
Gene Symbol: HDAC3
4 Cross references
155 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSSLDG00000021093
Gene Symbol: HDAC4
3 Cross references
202 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSSLDG00000004180
Gene Symbol: HDAC4
3 Cross references
196 Possible Orthologues:

Histone Deacetylase 5

Ensembl ID : ENSSLDG00000012743
Gene Symbol: HDAC5
1 Cross references
192 Possible Orthologues:

Histone Deacetylase 6

Ensembl ID : ENSSLDG00000006702
Gene Symbol: HDAC6
2 Cross references
180 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSSLDG00000019841
Gene Symbol: HDAC7
3 Cross references
189 Possible Orthologues:

Histone Deacetylase 7

Ensembl ID : ENSSLDG00000009997
Gene Symbol: HDAC7
1 Cross references
195 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSSLDG00000003140
Gene Symbol: HDAC8
3 Cross references
205 Possible Orthologues:

Hydroxycarboxylic Acid Receptor 1

Ensembl ID : ENSSLDG00000017799
Gene Symbol: HCAR1
2 Cross references
233 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSSLDG00000007880
Gene Symbol: HCN4
4 Cross references
212 Possible Orthologues:

Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 4

Ensembl ID : ENSSLDG00000016225
Gene Symbol: HCN4
3 Cross references
221 Possible Orthologues:

Hypocretin Receptor 2

Ensembl ID : ENSSLDG00000000943
Gene Symbol: HCRTR2
3 Cross references
203 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).